ACADIA Pharmaceuticals
ACAD
#3646
Rank
A$4.24 B
Marketcap
$25.46
Share price
-2.44%
Change (1 day)
-8.43%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2024 (TTM): A$0.40 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are A$0.95 Billion. , an increase over its 2023 earnings that were of -A$80.13 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2024

Annual earnings

Year Earnings Change
2024 A$0.40 B-605.67%
2023 -A$80.13 Million-76.09%
2022 -A$0.34 Billion27.41%
2021 -A$0.27 Billion-40.38%
2020 -A$0.45 Billion19.88%
2019 -A$0.37 Billion-3.92%
2018 -A$0.39 Billion-15.04%
2017 -A$0.46 Billion6.33%
2016 -A$0.43 Billion64.55%
2015 -A$0.26 Billion77.47%
2014 -A$0.15 Billion143.69%
2013 -A$59.58 Million81.93%
2012 -A$32.75 Million-8.73%
2011 -A$35.88 Million-251.39%
2010 A$23.69 M-133.2%
2009 -A$71.39 Million-30.82%
2008 -A$0.11 Billion6.43%
2007 -A$96.96 Million25.89%
2006 -A$77.02 Million36.99%
2005 -A$56.22 Million37.22%
2004 -A$40.97 Million19.96%
2003 -A$34.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$63.84 Million-115.76%๐Ÿ‡บ๐Ÿ‡ธ USA
A$17.44 B 4,206.11%๐Ÿ‡บ๐Ÿ‡ธ USA
A$19.90 B 4,813.46%๐Ÿ‡บ๐Ÿ‡ธ USA
A$27.38 B 6,658.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$13.16 Billion-3,346.73%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$60.65 Million-114.97%๐Ÿ‡บ๐Ÿ‡ธ USA